Clinical impact of "pure" empirical catheter ablation of slow-pathway in patients with non-ECG documented clinical on-off tachycardia.
Shqipe GerguriNikesh JathannaTina LinPatrick MüllerLukas ClasenJan SchmidtMuhammed KurtDong-In ShinChristian BlockhausMalte KelmAlexander FürnkranzHisaki MakimotoPublished in: European journal of medical research (2018)
A higher incidence of other AT and subjective symptom persistence are demonstrated after peCaSP, while peCaSP improves clinical symptoms in 60% of patients with non-documented on-off tachycardia.